PressReleases
Press Releases
Kineta Press Releases
Kineta Announces Successful Completion of Pre-IND Meeting with the FDA for KVA12.1 Phase 1/2 clinical studies of the company’s anti-VISTA
Kineta Announces First Participant Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of KCP506
Kineta Announces First Participant Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of KCP506 Seattle, WA — (July 14,
Kineta’s Thierry Guillaudeux Participated on Multiple Panel Presentations During Virtual Symposium on VISTA
Kineta’s Thierry Guillaudeux Participated on Multiple Panel Presentations During Virtual Symposium on VISTA: A New Immunotherapy Approach to Treating Cancer
Kineta to Participate in “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond” Virtual Symposium
Kineta to Participate in “VISTA: A New Immune Checkpoint in Cancer, Autoimmunity and Beyond” Virtual Symposium Seattle, WA — (June
Kineta Presents New Preclinical Data on its Lead VISTA Antagonist Antibody at the AACR Annual Meeting 2021
Kineta Presents New Preclinical Data on its Lead VISTA Antagonist Antibody at the AACR Annual Meeting 2021 Seattle, WA —
Kineta Presents Clinical Study Results of LHF-535 at the International Conference on Antiviral Research (ICAR)
Kineta Presents Clinical Study Results of LHF-535 at the International Conference on Antiviral Research (ICAR) Safety, tolerability and pharmacokinetic profile
Kineta Presenting at Multiple Investor Conferences in March 2021
Kineta Presenting at Multiple Investor Conferences in March 2021 Seattle, WA — (March 3, 2021) Kineta, Inc., a clinical stage
Kineta Announces First Participant Dosed in Phase 1 Clinical Trial of KCP506, A Novel Non-Opioid for the Treatment of Chronic Pain
Kineta Announces First Participant Dosed in Phase 1 Clinical Trial of KCP506, A Novel Non-Opioid for the Treatment of Chronic
Disclaimer: The Press Releases on this page are provided for historical purposes only. The information contained in each [press release/news article/event] is accurate only as of the date each was originally issued. Kineta disavows any obligation to update the information after the date of their issuance.